MARKET

NMRA

NMRA

Neumora Therapeutics Inc
NASDAQ
0.4289
-0.0041
-0.95%
After Hours: 0.4590 +0.0301 +7.02% 19:51 11/13 EST
OPEN
0.4368
PREV CLOSE
0.4330
HIGH
0.4862
LOW
0.4207
VOLUME
569.29K
TURNOVER
--
52 WEEK HIGH
3.650
52 WEEK LOW
0.3154
MARKET CAP
80.59M
P/E (TTM)
-0.3478
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NMRA last week (1102-1106)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 11/06 21:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 11/03 17:05
Weekly Report: what happened at NMRA last week (1026-1030)?
Weekly Report · 11/02 09:23
Neumora Therapeutics Faces Nasdaq Minimum Bid Price Warning
TipRanks · 10/30 21:07
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
Seeking Alpha · 10/29 19:44
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 10/27 21:05
Weekly Report: what happened at NMRA last week (1019-1023)?
Weekly Report · 10/26 09:22
More
About NMRA
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Navacaprant is being investigated in the KOASTAL pivotal Phase 3 program, evaluating navacaprant monotherapy in patients with moderate to severe MDD. The Company's next advanced product candidate is NMRA-511, which is a highly selective, novel antagonist of the vasopressin 1a receptor (V1aR) being developed for the treatment of agitation associated with dementia due to Alzheimer's disease (AD).

Webull offers Neumora Therapeutics Inc stock information, including NASDAQ: NMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NMRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NMRA stock methods without spending real money on the virtual paper trading platform.